SBIR/STTR Research Award

PeriPath: A Novel Pericardial Access Tool for Epicardial Pacing and Defibrillation

Award identifier 7e15f88db65a29203f598a897a72b9457e26593b43201607a7c6a5623c5b2568Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,730

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PeriCor LLC
Proposal award date
2018-08-01
Contract end date
2020-01-31
UEI
ZTDDUKBQBRJ7
Solicitation number
PA17-302
Topic code
NHLBI

Research abstract

Project SummaryEach yearnearlyinfants in the United States are born with a complex congenital heart disease that requires surgical intervention within the first year of lifeFor infants and young children with heart rhythm abnormalitiesinterventional treatment can be especially difficultas the size of their vasculature and or congenital anomalies typically preclude a transvenous approach for implanting a cardiac device such as a pacemaker or defibrillatorAs a resultinfants must undergo a sternotomy or thoracotomy to access the epicardial surface of the heartWe have developed a novel minimally invasive pericardial access tool to deliver pacing and defibrillation leads to the epicardial surface of the heart under direct visualization from an endoscopeUtilizing this toolwe hypothesize that we can safely and effectively deliver pacing and defibrillation therapy through a single small portBy using a percutaneous approachthis should reduce pain and risk of infectiondecrease procedure timesand minimize operative complications from an open surgical approachIn additiondirect visualization of the procedure makes it safer than blind pericardial puncturesOur team has utilized an immature porcine model for the acute implantation of cardiac devicesWe also demonstrated that cardiac therapy delivered by percutaneous approach was as safe and effective as an open surgical techniqueThe specificnear term goal of this project is to assess long term safety and efficacy of the implantation tool and techniques through the followingspecific aimsAimImprove the design and develop the process to manufacture the pericardial access tool for preclinical bench testingSuccess is defined as producing a minimum ofunits that pass preclinical bench testingsterilizationand post production quality controlsAimAssess the safety of the pericardial access tool in an acuteAimcomparison study to thoracic trocarsand the efficacyAimof accessing the pericardial space in a pericardial adhesion modelSuccess is defined as demonstrating safety of the procedure in acute infant pigletswith functional pacemakersdefibrillatorsmonths after implant in the efficacy studyThis research could have a transformative impact in changing current clinical practice by converting an open surgical approach to a minimally invasive percutaneous procedureWhile the study design focuses on the unique needs of infants and children with congenital heart diseaseextrapolation of these findings may benefit thousands of adult patients who have indications for cardiac resynchronization therapy but do not achieve successful implantation due to lack of transvenous access or adequate coronary sinus venous tributaries to pace key locations in the left ventriclewhich could be resolved with our proposed tools and techniques Project NarrativeWe are proposing novel tools and techniques to place pacemakers and cardiac defibrillators in infants and children with congenital heart diseasewho cannot receive devices via transvenous routeThis system allows for minimally invasive port access with direct visualization of the heart for safer implantation and avoiding the need for open chest surgeryWe hope this provides an important solution for this unique group of pediatric patients who are currently precluded from receiving standard pacemaker and defibrillator therapies

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2018–2024). Reported award amounts total $2,285,085. Reported amounts are not federal obligations.

Phases: Phase I, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.